Clinical Trial

Dietary Supplemental Kava

Study Description

A Phased Clinical Trial of Dietary Supplemental Kava: Kava Pharmacokinetics

Kava is a dietary supplement on the US market and is experiencing a resurgence of its use. Its pharmacokinetic information, however, is lacking which is important for its future effective usage as a dietary supplement or potentially as a botanical therapeutics. This phased trial, based on the recommendation from NIH, is to collect pharmacokinetic data of kava in healthy subjects.

Location

Locations Selected Location

Methods

Pharmaceutical medication involved Pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Drug - Kava Dietary Supplement

Participants will be given three 75mg kava capsules.

Additional Information

Official Study Title

A Phased Clinical Trial of Dietary Supplemental Kava: Kava Pharmacokinetics

Clinical Trial ID

NCT03843502

ParticipAid ID

e1w70b